IQVIA Holdings Inc

Stock Chart, Company Information, and Scan Results

$267.77(as of Sep 4, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

IQVIA Holdings Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$267.77
Ticker SymbolIQV
ExchangeNyse
SectorHealthcare
IndustryDiagnostics & Research
Employees94,000
CountyUSA
Market Cap$44,074.9M
EBIDTA3,048.0M
10-Day Moving Average262.81
P/E Ratio32.83
20-Day Moving Average254.01
Forward P/E Ratio18.66
50-Day Moving Average230.13
Earnings per Share8.03
200-Day Moving Average201.89
Profit Margin5.86%
RSI69.63
Shares Outstanding164.6M
ATR7.65
52-Week High271.80
Volume1,197,800
52-Week Low154.50
Most Recent Support Level257.18
Book Value6,301.0M
Most Recent Resistance Level265.25
P/B Ratio7.16
Upper Keltner271.23
P/S Ratio2.66
Lower Keltner236.79
Debt-to-Equity Ratio2.63
Next Earnings Date10/27/2026
Cash Surplus-6,906.0M
Next Ex-Dividend DateUnknown

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with Kexing Biopharm Co., Ltd. for biosimilar development. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.

IQVIA Holdings Inc In Our Stock Scanner

As of Sep 07, 2026
example chart graphic
Scan Name: 52-Week HighScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.